AAAAAA
Results: 1-25/58
Authors:
AJANI JA
FAIRWEATHER J
DUMAS P
PATT YZ
PAZDUR R
MANSFIELD PF
Citation: Ja. Ajani et al., PHASE-II STUDY OF TAXOL IN PATIENTS WITH ADVANCED GASTRIC-CARCINOMA, The cancer journal from Scientific American, 4(4), 1998, pp. 269-274
Authors:
HO DH
PAZDUR R
COVINGTON W
BROWN N
HUO YY
LASSERE Y
KURITANI J
Citation: Dh. Ho et al., COMPARISON OF 5-FLUOROURACIL PHARMACOKINETICS IN PATIENTS RECEIVING CONTINUOUS 5-FLUOROURACIL INFUSION AND ORAL URACIL PLUS N-1-(2'-TETRAHYDROFURYL)-5-FLUOROURACIL, Clinical cancer research, 4(9), 1998, pp. 2085-2088
Authors:
KIM J
ZHI JG
SATOH H
KOSSTWARDY SG
PASSE SM
PATEL IH
PAZDUR R
Citation: J. Kim et al., PHARMACOKINETICS OF RECOMBINANT HUMAN INTERFERON-ALPHA-2A COMBINED WITH 5-FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA, Anti-cancer drugs, 9(8), 1998, pp. 689-696
Authors:
HOFF PM
PAZDUR R
BENNER SE
CANETTA R
Citation: Pm. Hoff et al., UFT AND LEUCOVORIN - A REVIEW OF ITS CLINICAL DEVELOPMENT AND THERAPEUTIC POTENTIAL IN THE ORAL TREATMENT OF CANCER, Anti-cancer drugs, 9(6), 1998, pp. 479-490
Authors:
HOFF PM
LASSERE Y
ROYCE M
MATEI C
SLAUGHTER M
MEDGYESY D
LEE J
COYLE J
DEJAGER RL
PAZDUR R
Citation: Pm. Hoff et al., PHASE-I STUDY OF THE NEW CAMPTOTHECIN ANALOG DX-8951F ADMINISTERED BY24-HOUR CONTINUOUS-INFUSION, Annals of oncology, 9, 1998, pp. 246-246
Authors:
MEDGYESY D
DAKHIL S
MOORE D
SCALZO A
HOFF PM
ABBRUZZESE J
WINN R
PAZDUR R
Citation: D. Medgyesy et al., A PHASE-II TRIAL OF A 5-DAY CONTINUOUS-INFUSION OF 9-AMINO CAMPTOTHECIN (9-AC) WEEKLY FOR 3 WEEKS IN PATIENTS WITH ADVANCED COLORECTAL CARCINOMAS, Annals of oncology, 9, 1998, pp. 254-254
Authors:
ROYCE M
PAZDUR R
RODRIGUEZ GM
RINALDI DA
PATT YZ
BURRIS HA
Citation: M. Royce et al., PHASE-II STUDY OF DOCETAXEL IN PATIENTS WITH UNRESECTABLE CHOLANGIOCARCINOMA, Annals of oncology, 9, 1998, pp. 377-377
Authors:
SLAUGHTER M
DUMAS P
HOFF P
YANOWITZ C
SEMIOND D
WERTZ D
LEMOUHAER S
BESENVAL M
PAZDUR R
ANDERSON MD
Citation: M. Slaughter et al., CLINICAL AND PHARMACOKINETIC STUDY OF RPR 109881A (RPR) - A PHASE-I TRIAL OF A NOVEL TAXOID DERIVATIVE ADMINISTERED AS A 24-HOUR CONTINUOUS-INFUSION, Annals of oncology, 9, 1998, pp. 381-381
Authors:
BAKER SD
RAVDIN P
AYLESWORTH C
SMETZER L
BRUNO R
VERNILLET L
PAZDUR R
DOYLE G
HAMMERSHAIMB L
HOOKER E
BURRIS HA
ECKHARDT SG
JOHNSON T
KRAYNAK M
HAMMOND L
RODRIGUEZ G
WEISS G
ROWINSKY EK
Citation: Sd. Baker et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF DOCETAXEL IN CANCER-PATIENTS WITH LIVER DYSFUNCTION DUE TO MALIGNANCIES, Annals of oncology, 9, 1998, pp. 388-388
Authors:
LEBECQ A
DIERAS V
MARTY M
SESSA C
PAZDUR R
GELMON K
LATREILLE J
EISENHAUER E
BESENVAL M
RIVA A
DURRLEMAN S
Citation: A. Lebecq et al., PRELIMINARY EVALUATION OF THE MODIFIED CONTINUAL REASSESSMENT METHOD (MCRM) IN 4 PHASE-I STUDIES WITH RPR109881A, Annals of oncology, 9, 1998, pp. 488-488
Authors:
HOFF PM
BRITO R
SLAUGHTER M
MATEI C
LASSERE Y
JANJAN N
SKIBBER J
RANDOLPH J
BENNER S
PAZDUR R
ANDERSON MD
Citation: Pm. Hoff et al., UFT, ORAL LEUCOVORIN (LV) AND RADIOTHERAPY (RT) FOR PATIENTS WITH RESECTABLE RECTAL-CARCINOMA - AN EFFECTIVE ORAL PREOPERATIVE REGIMEN, Annals of oncology, 9, 1998, pp. 595-595
Authors:
MATEI C
NEMUNAITIS J
GRIEGO C
HOFF P
HANHAM A
CALLAHAN J
PAZDUR R
Citation: C. Matei et al., PHASE-I TRIAL OF BOF-A2 (EMITEFUR) PLUS LEUCOVORIN (LV) IN PATIENTS WITH ADVANCED COLORECTAL-CANCER (CRC), Annals of oncology, 9, 1998, pp. 639-639
Authors:
GEYER C
NEMUNAITIS J
HOFF P
GRIEGO C
HANHAM A
CALLAHAN H
PAZDUR R
Citation: C. Geyer et al., PHASE-I TRIAL OF BOF-AS (EMITEFUR) - A NOVEL ORAL FLUORINATED PYRIMIDINE, Annals of oncology, 9, 1998, pp. 640-640
Authors:
PAZDUR R
Citation: R. Pazdur, CLINICAL STATUS AND FUTURE-DIRECTIONS OF IRINOTECAN, Oncology, 12(8), 1998, pp. 11-12
Authors:
PAZDUR R
Citation: R. Pazdur, IRINOTECAN - TOWARD CLINICAL END-POINTS IN DRUG DEVELOPMENT, Oncology, 12(8), 1998, pp. 13-21
Authors:
PAZDUR R
HOFF PM
MEDGYESY D
ROYCE M
BRITO RA
Citation: R. Pazdur et al., THE ORAL FLUOROURACIL PRODRUGS, Oncology, 12(10), 1998, pp. 48-51
Authors:
PAZDUR R
LASSERE Y
DIAZCANTON E
HO DH
Citation: R. Pazdur et al., PHASE-I TRIAL OF URACIL-TEGAFUR (UFT) PLUS ORAL LEUCOVORIN - 28-DAY SCHEDULE, Cancer investigation, 16(3), 1998, pp. 145-151
Authors:
ILSON DH
AJANI J
BHALLA K
FORASTIERE A
HUANG Y
PATEL P
MARTIN L
DONEGAN J
PAZDUR R
REED C
KELSEN DP
Citation: Dh. Ilson et al., PHASE-II TRIAL OF PACLITAXEL, FLUOROURACIL, AND CISPLATIN IN PATIENTSWITH ADVANCED-CARCINOMA OF THE ESOPHAGUS, Journal of clinical oncology, 16(5), 1998, pp. 1826-1834
Authors:
OCONNELL MJ
LAURIE JA
KAHN M
FITZGIBBONS RJ
ERLICHMAN C
SHEPHERD L
MOERTEL CG
KOCHA WI
PAZDUR R
WIEAND HS
RUBIN J
VUKOV AM
DONOHUE JH
KROOK JE
FIGUEREDO A
Citation: Mj. Oconnell et al., PROSPECTIVELY RANDOMIZED TRIAL OF POSTOPERATIVE ADJUVANT CHEMOTHERAPYIN PATIENTS WITH HIGH-RISK COLON-CANCER, Journal of clinical oncology, 16(1), 1998, pp. 295-300
Authors:
AJANI JA
PAZDUR R
DUMAS P
FAIRWEATHER J
Citation: Ja. Ajani et al., PHASE-II STUDY OF PROLONGED INFUSION OF TAXOL IN PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA, Investigational new drugs, 16(2), 1998, pp. 175-177
Authors:
MEYERS CA
KUDELKA AP
CONRAD CA
GELKE CK
GROVE W
PAZDUR R
Citation: Ca. Meyers et al., NEUROTOXICITY OF CI-980, A NOVEL MITOTIC INHIBITOR, Clinical cancer research, 3(3), 1997, pp. 419-422
Authors:
PAZDUR R
DIAZCANTON E
BALLARD WP
BRADOF JE
GRAHAM S
ARBUCK SG
ABBRUZZESE JL
WINN R
Citation: R. Pazdur et al., PHASE-II TRIAL OF 9-AMINOCAMPTOTHECIN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN METASTATIC COLORECTAL-CARCINOMA, Journal of clinical oncology, 15(8), 1997, pp. 2905-2909
Authors:
PATT YZ
HOQUE A
LOZANO R
PAZDUR R
CHASE J
CARRASCO H
CHUANG V
DELPASSAND ES
ELLIS L
CURLEY S
ROH M
JONES DV
Citation: Yz. Patt et al., PHASE-II TRIAL OF HEPATIC ARTERIAL INFUSION OF FLUOROURACIL AND RECOMBINANT HUMAN INTERFERON ALFA-2B FOR LIVER METASTASES OF COLORECTAL-CANCER REFRACTORY TO SYSTEMIC FLUOROURACIL AND LEUCOVORIN, Journal of clinical oncology, 15(4), 1997, pp. 1432-1438
Authors:
PAZDUR R
MEYERS C
DIAZCANTON E
ABBRUZZESE JL
PATT Y
GROVE W
AJANI J
Citation: R. Pazdur et al., PHASE-II TRIAL OF INTRAVENOUS CI-980 (NSC-370147) IN PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA - MODEL FOR PROSPECTIVE EVALUATION OF NEUROTOXICITY, American journal of clinical oncology, 20(6), 1997, pp. 573-576
Authors:
PAZDUR R
LASSERE Y
DIAZCANTON E
BREADY B
HO DH
Citation: R. Pazdur et al., PHASE-I TRIAL OF URACIL-TEGAFUR (UFT) PLUS ORAL LEUCOVORIN - 14-DAY SCHEDULE, Investigational new drugs, 15(2), 1997, pp. 123-128